Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

H. R. Mali, S. A. Siddiqui, Madhur K. Garg, R. K. Singh, M. L B Bhatt

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalIndian Journal of Clinical Biochemistry
Volume13
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Radiotherapy
Copper
Radiation
Serum
Irradiation
Neoplasms
Dosimetry
Therapeutics
Monitoring

Keywords

  • Malignancy
  • Radiotherapy
  • Serum copper

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy. / Mali, H. R.; Siddiqui, S. A.; Garg, Madhur K.; Singh, R. K.; Bhatt, M. L B.

In: Indian Journal of Clinical Biochemistry, Vol. 13, No. 1, 1998, p. 36-40.

Research output: Contribution to journalArticle

Mali, H. R. ; Siddiqui, S. A. ; Garg, Madhur K. ; Singh, R. K. ; Bhatt, M. L B. / Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy. In: Indian Journal of Clinical Biochemistry. 1998 ; Vol. 13, No. 1. pp. 36-40.
@article{7ce36950a27e46c0bfb2e22e00fbb094,
title = "Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy",
abstract = "Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.",
keywords = "Malignancy, Radiotherapy, Serum copper",
author = "Mali, {H. R.} and Siddiqui, {S. A.} and Garg, {Madhur K.} and Singh, {R. K.} and Bhatt, {M. L B}",
year = "1998",
language = "English (US)",
volume = "13",
pages = "36--40",
journal = "Indian Journal of Clinical Biochemistry",
issn = "0970-1915",
publisher = "Springer India",
number = "1",

}

TY - JOUR

T1 - Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

AU - Mali, H. R.

AU - Siddiqui, S. A.

AU - Garg, Madhur K.

AU - Singh, R. K.

AU - Bhatt, M. L B

PY - 1998

Y1 - 1998

N2 - Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

AB - Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

KW - Malignancy

KW - Radiotherapy

KW - Serum copper

UR - http://www.scopus.com/inward/record.url?scp=77950096797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950096797&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 36

EP - 40

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -